ETN
68
-5
CMI
56
-4
AON
54
-2
CTAS
61
-3
EIX
53
-8
AMG
50
-4
LEN
17
-4
PFG
43
-7
NKE
28
-8
JPM
69
-5
FMC
33
-4
VFC
40
-19
BK
75
-5
LRCX
56
-3
AAL
39
-3
CFG
78
-8
CME
64
2
STZ
33
-2
CI
40
-8
PX
65
-7
ETN
68
-5
CMI
56
-4
AON
54
-2
CTAS
61
-3
EIX
53
-8
AMG
50
-4
LEN
17
-4
PFG
43
-7
NKE
28
-8
JPM
69
-5
FMC
33
-4
VFC
40
-19
BK
75
-5
LRCX
56
-3
AAL
39
-3
CFG
78
-8
CME
64
2
STZ
33
-2
CI
40
-8
PX
65
-7
Financhill
Back

Medpace Holdings Vs. Citius Pharmaceuticals Industry Stock Comparison

Sell
43

MEDP
Medpace Holdings

Last Price:
$293.13
Seasonality Move:
23.48%
Sell
25

CTXR
Citius Pharmaceuticals

Last Price:
$0.72
Seasonality Move:
-17.5%
Sell
43
Medpace Holdings (MEDP) is a Sell

Is Medpace Holdings a Buy, Sell or Hold?

  • The current Medpace Holdings [MEDP] share price is $295.77. The Score for MEDP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MEDP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

  • The current Citius Pharmaceuticals [CTXR] share price is $0.68. The Score for CTXR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CTXR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MEDP Stock Price Chart

What is Medpace Holdings's stock price today?

  • The Medpace Holdings share price today is $295.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEDP is experiencing slight selling pressure.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

  • The Citius Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.

MEDP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 46.57 Sell
Chaikin Money Flow: -150063 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (292.2 - 306.88) Sell
Bollinger Bands (100): (301.68 - 343.96) Sell

CTXR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 36.32 Sell
Chaikin Money Flow: -168518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.72 - 0.88) Sell
Bollinger Bands (100): (0.86 - 2.94) Sell

MEDP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 303.26 Sell
20-day SMA: 301.69 Sell
50-day SMA: 304.87 Sell
200-day SMA: 336.55 Sell
8-day EMA: 301.63 Sell
20-day EMA: 301.43 Sell
50-day EMA: 307.05 Sell
200-day EMA: 329.76 Sell

CTXR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.8 Sell
20-day SMA: 0.78 Sell
50-day SMA: 1.05 Sell
200-day SMA: 6.05 Sell
8-day EMA: 0.77 Sell
20-day EMA: 0.82 Sell
50-day EMA: 1.17 Sell
200-day EMA: 5.73 Sell

Medpace Holdings Earnings Growth & MEDP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.70 per share, and an increase next year of $0.45 per share.

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.02 per share, and an increase next year of $1.96 per share.

Medpace Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Citius Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):